We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.6
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.82% |
| 2 | Technology | 16.24% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Healthcare | 3.98% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
| $31.7M | 0.38% |
638,871
-166,137
| -21% | -$8.12M |
2025 Q4
2 quarters
|
|
52
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.6B
| $27.3M | 0.32% |
266,453
-2,070
| -0.8% | -$195K |
2025 Q4
2 quarters
|
|
53
JPMorgan Chase
JPM
$888B
| $27.2M | 0.32% |
83,239
+2,559
| +3% | +$795K |
2025 Q4
2 quarters
|
|
54
JPMorgan Active Bond ETF
JBND
$8.83B
| $27.2M | 0.32% |
508,429
+78,899
| +18% | +$4.22M |
2025 Q4
2 quarters
|
|
55
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23B
| $26.8M | 0.32% |
73,173
+20,495
| +39% | +$6.98M |
2025 Q4
2 quarters
|
|
56
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $26.6M | 0.32% |
372,838
+78,592
| +27% | +$5.47M |
2025 Q4
2 quarters
|
|
57
Hewlett Packard
HPE
$93.1B
| $26.4M | 0.31% |
585,562
+419,661
| +253% | +$15.2M |
2025 Q4
2 quarters
|
|
58
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.7B
| $26.4M | 0.31% |
108,531
+10,960
| +11% | +$2.55M |
2025 Q4
2 quarters
|
|
59
Johnson & Johnson
JNJ
$634B
| $26.2M | 0.31% |
103,310
+10,692
| +12% | +$2.49M |
2025 Q4
2 quarters
|
|
60
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
| $25.8M | 0.31% |
307,490
+85,967
| +39% | +$7.03M |
2025 Q4
2 quarters
|
|
61
Graphic Packaging
GPK
$2.43B
| $25.1M | 0.3% |
2,372,069
+18,446
| +0.8% | +$188K |
2025 Q4
2 quarters
|
|
62
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $25M | 0.3% |
33,412
+1,343
| +4% | +$974K |
2025 Q4
2 quarters
|
|
63
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.8B
| $24.5M | 0.29% |
205,387
-5,494
| -3% | -$594K |
2025 Q4
2 quarters
|
|
64
AbbVie
ABBV
$495B
| $22.7M | 0.27% |
90,294
-8,228
| -8% | -$1.77M |
2025 Q4
2 quarters
|
|
65
ConocoPhillips
COP
$165B
| $22.5M | 0.27% |
216,741
+64,202
| +42% | +$7.61M |
2025 Q4
2 quarters
|
|
66
Coca-Cola
KO
$386B
| $21.9M | 0.26% |
269,431
+49,305
| +22% | +$3.89M |
2025 Q4
2 quarters
|
|
67
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.73B
| $21.9M | 0.26% |
200,367
-18,236
| -8% | -$1.88M |
2025 Q4
2 quarters
|
|
68
McDonald's
MCD
$167B
| $21.8M | 0.26% |
80,510
+537
| +0.7% | +$154K |
2025 Q4
2 quarters
|
|
69
Mastercard
MA
$523B
| $21.7M | 0.26% |
42,301
+2,184
| +5% | +$1.09M |
2025 Q4
2 quarters
|
|
70
Amphenol
APH
$213B
| $21.3M | 0.25% |
241,876
+29,718
| +14% | +$2.14M |
2025 Q4
2 quarters
|
|
71
Vanguard Russell 3000 ETF
VTHR
$4.97B
| $21.2M | 0.25% |
63,886
-2,366
| -4% | -$757K |
2025 Q4
2 quarters
|
|
72
Berkshire Hathaway Class B
BRK.B
$1.11T
| $20.9M | 0.25% |
41,832
+1,588
| +4% | +$763K |
2025 Q4
2 quarters
|
|
73
Fidelity Blue Chip Growth ETF
FBCG
$7.69B
| $20.6M | 0.25% |
331,714
+26,302
| +9% | +$1.56M |
2025 Q4
2 quarters
|
|
74
iShares MSCI EAFE ETF
EFA
$76.5B
| $20.5M | 0.24% |
197,397
+11,779
| +6% | +$1.21M |
2025 Q4
2 quarters
|
|
75
UnitedHealth
UNH
$340B
| $20.3M | 0.24% |
48,833
+5,034
| +11% | +$1.87M |
2025 Q4
2 quarters
|
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.